Sign inJoin waitlistJoin the waitlist

Cristina Ferrone

Vice Chair, Cedars Sinai Medical Center · UCLA David Geffen School of Medicine/UCLA Medical Center

Credentials: · · · · ·

History

Cedars Sinai Medical Center Hospital · UCLA David Geffen School of Medicine/UCLA Medical Center
Present
Surgical Oncology Department · Cedars-Sinai Medical Center
Present
Cancer Clinical Services · Cedars-Sinai Medical Center
Present

Complex General Surgical Oncology
Memorial Sloan Kettering Cancer Center
2004–2006
Massachusetts General Hospital
1997–2004
Washington University School of Medicine
1993–1997
University of Pennsylvania
1989–1993

Research

Glutamine supports pancreatic cancer growth through a KRAS-regulated metabolic pathway
Nature · 2013 · 1,682 citations
Potential role of intratumor bacteria in mediating tumor resistance to the chemotherapeutic drug gemcitabine
Science · 2017 · 1,422 citations
Pancreatic Adenocarcinoma, Version 2.2021, NCCN Clinical Practice Guidelines in Oncology
Journal of the National Comprehensive Cancer Network · 2021 · 1,081 citations

KL
Keith Lillemoe
151 papers
Carlos Castillo
142 papers
Motaz Qadan
109 papers · 1 as a fellow
AW
Andrew Warshaw
97 papers
Vikram Deshpande
70 papers
Theodore Hong
64 papers
Jennifer Wo
51 papers
David Ryan
47 papers
LB
Lawrence Blaszkowsky
39 papers
JC
Jeffrey Clark
38 papers
MM
Mari Mino-Kenudson
38 papers
AZ
Andrew Zhu
36 papers

Grants

Tumor Downstaging with Small Molecule Therapeutics to Enhance Uveal Melanoma Metastasis Eradication by B7-H3 CAR T Cells
National Cancer Institute · R03
Contact PI · $167K · Cedars-Sinai Medical Center
2023–2025
Potential Role of Brachyury in HLA Class I Antigen Processing Machinery Component Downregulation in Chordoma Cells
National Cancer Institute · R03
Contact PI · $77.4K · Cedars-Sinai Medical Center
2020–2024
B7-H3 CAR T Cell-Based Immunotherapy Combined with Losartan to Counteract Desmoplasia for the Treatment of Pancreatic Ductal Adenocarcinoma (PDAC)
National Cancer Institute · R03
PI · $167.2K · Massachusetts General Hospital
2021–2023
IL-15 TRiKES-Based Specific Immunotherapy of Pancreatic Ductal Adenocarcinoma
National Cancer Institute · R03
PI · $177.3K · Massachusetts General Hospital
2018–2021

Clinical trials

Feasibility Study of LUM Imaging System for Pancreatic Cancer
Principal investigator · Withdrawn
Lumicell, Inc.
2026
Pilot Study of GVAX in Colorectal Cancer Cells
Principal investigator · Terminated · Phase 1
Massachusetts General Hospital
2013–2020
Management of Incidentally Discovered Pancreatic Cysts
Principal investigator · Terminated · Phase 3
Massachusetts General Hospital
2007–2012
Testing the Use of the Usual Chemotherapy Before and After Surgery for Removable Pancreatic Cancer
Study chair · Active not recruiting · Phase 3
Alliance for Clinical Trials in Oncology
2020–2030